Press Releases
Treatment Phase for Lead Clinical Candidate PH-762 Dose Escalation Trial is Complete with Favorable Safety, Tolerability and Pathology Data 2025...
Via Newsfile · March 5, 2026
The St. Joe Company (NYSE: JOE) (“St. Joe”) announces a new builder relationship and execution of a contract for homesites with national home builder PulteGroup, Inc. (NYSE: PHM)—the third largest homebuilding company in the nation, with a diversified portfolio serving a broad range of buyers. Plans call for these new homesites to be located in two gated communities along Highway 388, east of State Road 79 near Watersound® West Bay Center. Both communities are planned within the Pigeon Creek Detailed Specific Area Plan, which was approved by Bay County in 2025.
By The St. Joe Company · Via Business Wire · March 5, 2026
Traeger, Inc. (“Traeger” or the “Company”) (NYSE: COOK), creator and category leader of the wood pellet grill, today announced its financial results for the fourth quarter and year ended December 31, 2025.
By Traeger, Inc. · Via Business Wire · March 5, 2026
Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today reported financial results for the fourth fiscal quarter and fiscal year ended January 31, 2026.
By Marvell Technology, Inc. · Via Business Wire · March 5, 2026
Guidewire (NYSE: GWRE) today announced its financial results for the fiscal quarter ended January 31, 2026.
By Guidewire · Via Business Wire · March 5, 2026
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, March 18, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
By Hyperfine, Inc. · Via Business Wire · March 5, 2026
J.B. Hunt Transport Services, Inc. (Nasdaq: JBHT) today announced that it has been approved to have its common stock dually listed on Nasdaq Texas, LLC (Nasdaq Texas). J.B. Hunt President and CEO Shelley Simpson joined key industry and Nasdaq leaders and Texas state officials at today’s closing bell ceremony commemorating the launch of the Nasdaq Texas exchange.
By J.B. Hunt Transport Services, Inc. · Via Business Wire · March 5, 2026
ESS Tech, Inc. (“ESS,” “ESS, Inc.” or the “Company”) (NYSE:GWH), a leading manufacturer of iron flow long-duration energy storage (“LDES”) systems for commercial and utility-scale applications, today announced financial results for its fourth quarter and full year ended December 31, 2025.
By ESS, Inc. · Via Business Wire · March 5, 2026
MP Materials Corp. (NYSE: MP) today announced that company executives will participate in the following conferences:
By MP Materials · Via Business Wire · March 5, 2026
Entravision, a global media and advertising technology company, announced three promotions in its US Media leadership team:
By Entravision · Via Business Wire · March 5, 2026
a.k.a. Brands Holding Corp. (NYSE: AKA), a portfolio of next generation fashion brands, today announced financial results for the fourth quarter and full year ended December 31, 2025.
By a.k.a. Brands Holding Corp. · Via Business Wire · March 5, 2026
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today reported its fourth-quarter 2025 financial results and affirmed its key clinical development milestones.
By Contineum Therapeutics, Inc. · Via Business Wire · March 5, 2026
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) (“Grid Dynamics” or the “Company”), a leader in enterprise-level artificial intelligence and digital transformation, today announced its results for the fourth quarter and full year ended December 31, 2025.
By Grid Dynamics Holdings, Inc. · Via Business Wire · March 5, 2026
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the Company will participate in the Sidoti Small-Cap Virtual Conference on March 18 and 19. CRA Chairman and Chief Executive Officer Paul Maleh is scheduled to present at 10:00 a.m. ET on Wednesday, March 18, 2026. A live webcast will be available on the Company’s investor relations website. An archived replay will be available approximately one hour after the event.
By Charles River Associates · Via Business Wire · March 5, 2026
BERKELEY, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for fourth quarter and full year 2025 and provided an overview of recent corporate highlights.
By Caribou Biosciences, Inc. · Via GlobeNewswire · March 5, 2026
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2025. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, March 5, 2026, at 4:30 p.m. ET.
By Owlet, Inc. · Via Business Wire · March 5, 2026
WILMINGTON, Del., March 05, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (NASDAQ:GBLI) (“GBLI”) announced that its Board of Directors has approved a distribution payment of $0.35 per common share to be paid on March 30, 2026 to all shareholders of record as of the close of business on March 20, 2026.
By Global Indemnity Group, LLC · Via GlobeNewswire · March 5, 2026
AECOM (NYSE: ACM), the trusted global infrastructure leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share as part of its ongoing quarterly dividend program. The dividend is payable on April 17, 2026 to stockholders of record as of the close of business on April 1, 2026.
By AECOM · Via Business Wire · March 5, 2026
Roku, Inc. (Nasdaq: ROKU) announced today that Dan Jedda, CFO and COO, will participate in a fireside chat at the 34th Annual Media, Internet & Telecom Conference hosted by Deutsche Bank on Tuesday, March 10. Mr. Jedda is scheduled to appear at 1:30 PM ET.
By Roku, Inc. · Via Business Wire · March 5, 2026
Phreesia today announced that Tara Sheehy, Senior Director of Client Experience for Phreesia Network Solutions, has been named to the MM+M Women to Watch class of 2026.
By Phreesia, Inc. · Via Business Wire · March 5, 2026
WSFS Bank, the primary subsidiary of WSFS Financial Corporation (Nasdaq: WSFS), announced today that Rene Gonzales has joined the organization as Senior Vice President, Chief Technology Officer. In this role, Gonzales reports to Allan Matyger, Executive Vice President, Chief Information Officer, and leads the company’s technology strategy, infrastructure, and operations to support its continued growth and innovation.
By WSFS Financial Corporation · Via Business Wire · March 5, 2026
SAXONBURG, Pa., March 05, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of Thermadite™ 800 Liquid Cold Plates (LCP) for next-generation AI accelerator cooling.
By Coherent Corp. · Via GlobeNewswire · March 5, 2026
Torrid Holdings Inc. (“Torrid” or the “Company”) (NYSE: CURV), a direct-to-consumer apparel, intimates, and accessories brand in North America for women sizes 10 to 30, today announced that it will release fourth quarter and fiscal 2025 financial results after market close on Thursday, March 19, 2026. Management will host a conference call that afternoon at 4:30 p.m. Eastern Time to discuss its financial results.
By Torrid Holdings Inc. · Via Business Wire · March 5, 2026
Fourth Quarter 2025 Highlights
By AerSale Inc · Via GlobeNewswire · March 5, 2026
Completed pre-IND meeting following MGX-001 preclinical data demonstrating curative FVIII activity in non-human primates (NHPs) and remains on track for global regulatory submission including investigational new drug application (“IND”) in 4Q 2026
By Metagenomi, Inc. · Via GlobeNewswire · March 5, 2026
- American Place Casino Continued Its Strong Growth, With Revenues Increasing 13.1% for the Year and 11.0% in the Fourth Quarter
By Full House Resorts, Inc. · Via GlobeNewswire · March 5, 2026
ROGERS, Ark., March 05, 2026 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2026 third quarter financial results on Thursday, March 12, 2026, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results.
By America's Car-Mart, Inc. · Via GlobeNewswire · March 5, 2026
SOUTH SAN FRANCISCO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update, including highlights of pipeline progress.
By TheRas, Inc. (d/b/a BBOT) · Via GlobeNewswire · March 5, 2026
LEBEC, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE: TRC), a diversified real estate development and agribusiness company, today announced it will release its fourth quarter and full year 2025 operating and financial results before the market opens on March 19, 2026. In connection with this announcement, the Company will host a conference call on March 19, 2026 at 5:00 p.m. Eastern Time. During the call, President & CEO Matt Walker and CFO Robert Velasquez will provide an update on the Company’s recent initiatives and financial results.
By Tejon Ranch Co · Via GlobeNewswire · March 5, 2026
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
By Nyxoah · Via GlobeNewswire · March 5, 2026
2025, a Transformational Year Marked by Strategic Steps Designed to Enhance Shareholder Value: the Merger with Logan Ridge, Corporate Rebranding and Completion of a Tender Offer
By BCP Investment Corp. · Via GlobeNewswire · March 5, 2026
BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the following upcoming investor conference:
By Amneal Pharmaceuticals LLC · Via GlobeNewswire · March 5, 2026
GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026
By CAMP4 Therapeutics · Via GlobeNewswire · March 5, 2026
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outside North America Anticipated Year-End 2026
By Atea Pharmaceuticals, Inc. · Via GlobeNewswire · March 5, 2026
TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reported financial results for the fourth quarter and full year ended December 31, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).
By Profound Medical Corp. · Via GlobeNewswire · March 5, 2026
Company Advances Strategic Transition, Expands IntentKey®, and Provides 2026 Outlook
By Inuvo Inc. · Via GlobeNewswire · March 5, 2026
TARRYTOWN, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation at the Barclays 28th Annual Global Healthcare Conference at 9:00 a.m. ET on Tuesday, March 10, 2026.
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · March 5, 2026
BELTSVILLE, Md., March 05, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported full year 2025 financial results.
By NextCure · Via GlobeNewswire · March 5, 2026
Simply Home Improvement has unveiled its performance-driven approach to delivering qualified, exclusive leads to home improvement professionals across the United States. The strategy eliminates the traditional pain points that have long plagued contractors seeking consistent work: no shared leads, no ad spend, no setup fees, and no long-term contracts.
Via Get News · March 5, 2026
Revenue up 58% in Fourth Quarter, 53% for Year; Member Growth of 55% for YearAchieves Positive Net Income in Fourth Quarter; Significantly Narrows Net Loss for Full Year Delivers Positive Adjusted EBITDA for Full Year
By Omada Health, Inc. · Via GlobeNewswire · March 5, 2026
MEXICO CITY, March 05, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its February 2026 operational results:
By Grupo Aeroméxico, S.A.B. de C.V. · Via GlobeNewswire · March 5, 2026
Slowdown Studio, a design brand known for its integration of functional art and home decor, recently announced the official launch of its latest product, the Alma Throw woven blanket . Designed by Budapest-based artist Enikő Katalin Eged for the studio, the new woven blanket marks the first release of the 12 winning entries of the annual "Slowdown Art Comp," an annual international competition organized by the studio to discover and elevate contemporary talent.
Via Get News · March 5, 2026
Pattern Group Inc. (NASDAQ: PTRN), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, today announced financial results for the fourth quarter and full year ended December 31, 2025.
By Pattern Group Inc. · Via Business Wire · March 5, 2026
2PointZero Group PJSC (ADX: 2PointZero), a next-generation investment powerhouse focused on energy and consumer sectors, announced today that it has formally completed the transaction to acquire a majority position in ISEM, a leading European packaging group serving beauty, fashion, luxury, nutraceuticals and more, for AED 704 million through a combination of secondary and primary capital earmarked to accelerate organic and inorganic growth.
By 2PointZero Group PJSC · Via Business Wire · March 5, 2026
LIMASSOL, Cyprus, March 05, 2026 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its preliminary, unaudited financial and operational results for the fourth quarter and twelve months ended December 31, 2025.
By GDEV Inc. · Via GlobeNewswire · March 5, 2026
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Apollo Global Management, Inc. (“Apollo” or the “Company”) (NYSE: APO) securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”). Apollo investors have until May 1, 2026 to file a lead plaintiff motion.
By The Law Offices of Frank R. Cruz · Via Business Wire · March 5, 2026
VisualVault, a leading provider of digital information and patient data management solutions, will be exhibiting at the HIMSS Global Health Conference & Exposition, March 9-12 at the Venetian Expo Center in Las Vegas, NV. VisualVault’s presence will be based within the Carahsoft Pavilion, booth 6424.
By VisualVault · Via Business Wire · March 5, 2026
Evommune, Inc. (NYSE: EVMN) (“Evommune” or the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.
By Evommune, Inc. · Via Business Wire · March 5, 2026
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announces financial results for the quarter and year ended December 31, 2025, and provides an operational update.
By TriSalus Life Sciences · Via Business Wire · March 5, 2026
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today reported its fourth quarter and full year 2025 financial and operating results and will host a conference call today at 4:30 p.m. Eastern Time to discuss these results and to provide a business update.
By Lineage Cell Therapeutics, Inc. · Via Business Wire · March 5, 2026